Sunbelt Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.2K Buy
+1,500
New +$48.3K ﹤0.01% 1045
2024
Q4
Sell
-212
Closed -$3.82K 1920
2024
Q3
$3.82K Hold
212
﹤0.01% 1496
2024
Q2
$3.44K Hold
212
﹤0.01% 1461
2024
Q1
$2.99K Hold
212
﹤0.01% 1454
2023
Q4
$2.21K Hold
212
﹤0.01% 1452
2023
Q3
$2.16K Hold
212
﹤0.01% 1469
2023
Q2
$1.6K Buy
+212
New +$1.72K ﹤0.01% 1470

Other funds holding TEVA

Sunbelt Securities's TEVA Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 1,500 shares worth $45.2K. The stake represents ﹤0.01% of the portfolio and ranks #1045 among its holdings. This is a return to the name: Sunbelt Securities previously reported a position in TEVA as recently as Q3 2024.

Sunbelt Securities first reported a position in TEVA in Q2 2023 and has held it in 7 quarters since. 652 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Sunbelt Securities held 1,500 shares of Teva Pharmaceuticals worth $45.2K as of Q1 2026.
  • Teva Pharmaceuticals was a new Sunbelt Securities position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1045 holding.
  • Sunbelt Securities first reported a position in Teva Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • 652 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.